Next Quarterly Earnings
Thursday, October 29, 2026
CW 44
Pre-Market
In 63 days
Pre-market — typically before 3:30 p.m. German time (before the US open at 9:30 a.m. New York time).
Kymera Therapeutics
Kymera Therapeutics is a leading US-based biotechnology company specializing in the development of targeted protein degradation (TPD) therapies. Through innovative technologies, the company addresses previously untreatable diseases, thereby revolutionizing modern drug discovery and therapeutic research.
Frequently asked questions
When will Kymera Therapeutics report its next quarterly earnings?
Kymera Therapeutics is scheduled to report its next quarterly earnings on 10/29/2026. Pre-market — typically before 3:30 p.m. German time (before the US open at 9:30 a.m. New York time).
When did Kymera Therapeutics last report quarterly earnings?
Kymera Therapeutics last reported quarterly earnings on 8/5/2026 (Q2 2026). Earnings per share (EPS) came in at -0.62 USD.
How does Kymera Therapeutics stock react to earnings?
Across its last 3 earnings reports, Kymera Therapeutics stock moved by ±2.1% on average the following day. The largest reaction was +4.8% on 02/26/2026; 2 of 3 reactions were positive.
How often has Kymera Therapeutics beaten expectations?
Kymera Therapeutics has beaten analyst EPS estimates in 2 of its last 5 evaluated quarters (beat rate: 40%).
How do I add the Kymera Therapeutics earnings dates to my calendar?
Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.
All Dates
Earnings statistics
Stock reaction to earnings
±2.1%
Avg. next-day move
+4.8%
Largest move (02/26/2026)
66.7%
Share of positive reactions
±7%
Avg. move after 7 days
Basis: price reactions to the last 3 report dates (close to close).
Estimates vs. results
2/5
Quarters above estimates
40%
Beat rate
+1.6%
Avg. EPS surprise
Basis: 5 quarters with an analyst estimate and reported EPS.
Past price reactions are not a reliable indicator of future performance.
Company Information
Name
Kymera Therapeutics
Country
🇺🇸
More Financial Information